For citations:
Baranov A.A., Vinogradova I.B., Anoshenkova O.N., Antipova O.V., Bogdanova E.A., Grabovetskaya Y.Y., Ilivanova E.P., Kalyagin A.N., Kushnir I.N., Lapkina N.A., Mokrousova M.V., Nesmeyanova O.B., Nikitina N.M., Shesternya P.A., Yudina N.V., Feist E., Nasonov E.L. Management of patients with rheumatoid arthritis in real clinical practice: Switching from interleukin 6 receptor inhibitors to interleukin 6 inhibitor (olokizumab). Rheumatology Science and Practice. 2023;61(3):307-319. (In Russ.) https://doi.org/10.47360/1995-4484-2023-307-319
Email this article 